ArticleOncotarget2015

Bruton's tyrosine kinase (Btk) inhibitor ibrutinib suppresses stem-like traits in ovarian cancer.

Muhammad Ary Zucha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.